Layer, Julian P. http://orcid.org/0000-0001-7692-7775
Fischer, Pascal
Dejonckheere, Cas S.
Sarria, Gustavo R.
Mispelbaum, Rebekka
Hattenhauer, Tessa
Wiegreffe, Shari
Glasmacher, Andrea R.
Layer, Katharina
Nour, Youness
Caglayan, Lara
Grau, Franziska
Müdder, Thomas
Köksal, Mümtaz
Scafa, Davide
Giordano, Frank A.
Lopez-Pastorini, Alberto
Stoelben, Erich
Schmeel, Leonard Christopher
Leitzen, Christina
Funding for this research was provided by:
Universitätsklinikum Bonn
Article History
Received: 14 August 2023
Accepted: 22 October 2023
First Online: 22 November 2023
Declarations
:
: J.P. Layer reports stocks and travel expenses from TME Pharma AG; travel expenses from Carl Zeiss Meditec AG; stocks and honoraria from Siemens Healthineers; and stocks from Bayer AG and BioNTech AG, all not related to this work. F.A. Giordano reports research grants and travel expenses from ELEKTA AB and Varian Medical Systems Inc.; grants, stocks, travel expenses, and honoraria from TME Pharma AG; research grants, travel expenses, and honoraria from Carl Zeiss Meditec AG; travel expenses and honoraria from Bristol-Myers Squibb, Cureteq AG, Guerbet SA, Roche Pharma AG, MSD Sharp and Dohme GmbH, and AstraZeneca GmbH; non-financial support from Oncare GmbH and Opasca GmbH. G.R. Sarria reports personal fees and travel expenses from Carl Zeiss Meditec AG; personal fees from Roche Pharma AG; personal fees from MedWave Clinical Trials; and travel expenses from Guerbet SA, not related to this work. P. Fischer, C.S. Dejonckheere, R. Mispelbaum, T. Hattenhauer, S. Wiegreffe, A.R. Glasmacher, K. Layer, Y. Nour, L. Caglayan, F. Grau, T. Müdder, M. Köksal, D. Scafa, A. Lopez-Pastorini, E. Stoelben, L.C. Schmeel, and C. Leitzen declare that they have no competing interests.
: The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of the University Hospital Bonn (approval number: 057/22). Informed consent was not required due to the retrospective character of this study.